Skip to main content
Top
Literature
1.
go back to reference Lau C, Ali MIM, Lin L, et al. Impact of bariatric surgery on oral anticancer drugs: an analysis of real-world data. Cancer Chemother Pharmacol. 2024;94:25–34.CrossRefPubMedPubMedCentral Lau C, Ali MIM, Lin L, et al. Impact of bariatric surgery on oral anticancer drugs: an analysis of real-world data. Cancer Chemother Pharmacol. 2024;94:25–34.CrossRefPubMedPubMedCentral
2.
go back to reference Goldberg SL. Bariatric surgery and oral chemotherapy: where is the dosing guidance? Cancer. 2023;129:1800–2.CrossRefPubMed Goldberg SL. Bariatric surgery and oral chemotherapy: where is the dosing guidance? Cancer. 2023;129:1800–2.CrossRefPubMed
3.
go back to reference Steenackers N, Vanuytsel T, Augustijns P, et al. Adaptations in gastrointestinal physiology after sleeve gastrectomy and Roux-en-Y gastric bypass. Lancet Gastroenterol Hepatol. 2021;6(3):225–37.CrossRefPubMed Steenackers N, Vanuytsel T, Augustijns P, et al. Adaptations in gastrointestinal physiology after sleeve gastrectomy and Roux-en-Y gastric bypass. Lancet Gastroenterol Hepatol. 2021;6(3):225–37.CrossRefPubMed
4.
go back to reference D’Amato S, Sofia M, Agosta M, et al. The impact of bariatric surgery on colorectal cancer risk. Surg Obes Relat Dis. 2023;19:144–57.CrossRefPubMed D’Amato S, Sofia M, Agosta M, et al. The impact of bariatric surgery on colorectal cancer risk. Surg Obes Relat Dis. 2023;19:144–57.CrossRefPubMed
5.
go back to reference Bland CM, Quidley AM, Love BL, et al. Long-term pharmacotherapy considerations in the bariatric surgery patient. Am J Health Syst Pharm. 2016;73(16):1230–42.CrossRefPubMed Bland CM, Quidley AM, Love BL, et al. Long-term pharmacotherapy considerations in the bariatric surgery patient. Am J Health Syst Pharm. 2016;73(16):1230–42.CrossRefPubMed
6.
go back to reference Garcia-Alfonso P, Martin AJM, Moran LO, et al. Oral drugs in the treatment of metastatic colorectal cancer. Ther Adv Med Oncol. 2021;13:1–16.CrossRef Garcia-Alfonso P, Martin AJM, Moran LO, et al. Oral drugs in the treatment of metastatic colorectal cancer. Ther Adv Med Oncol. 2021;13:1–16.CrossRef
7.
go back to reference Gennatas C, Michalaki V, Gennatas S. The role of capecitabine in the management of tumors of the digestive system. Rev Recent Clin Trials. 2009;4:1–11.CrossRefPubMed Gennatas C, Michalaki V, Gennatas S. The role of capecitabine in the management of tumors of the digestive system. Rev Recent Clin Trials. 2009;4:1–11.CrossRefPubMed
Metadata
Title
The Impact of Bariatric Procedures on the Efficacy of Capecitabine for the Management of Colorectal Cancer
Authors
Rodrick Babakhanlou
Aaron Scott
Publication date
07-12-2024
Publisher
Springer US
Published in
Obesity Surgery / Issue 1/2025
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-024-07622-6
SPONSORED

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by:
  • Viatris
Developed by: Springer Healthcare
Watch now
Video